株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

診断用マイクロ流体技術の特許情勢

Microfluidic Technologies for Diagnostic Applications Patent Landscape

発行 Knowmade 商品コード 524304
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
診断用マイクロ流体技術の特許情勢 Microfluidic Technologies for Diagnostic Applications Patent Landscape
出版日: 2017年01月31日 ページ情報: 英文
概要

当レポートでは、診断用マイクロ流体技術の特許情勢について取り上げ、ポートフォリオの規模、特許引用ネットワーク、特許出願国、ならびに現在の特許の法的状況から、主要な特許所有者の相対的な強みのランク付けおよび分析を提供しています。

イントロダクション

調査手法

主な出願者

エグゼクティブサマリー

特許情勢の概要

  • 特許発行の時間的発展
  • 特許出願諸国
  • 時間的発展:出願国別
  • 主な特許出願者のランキング
  • 主要企業のランキング
  • 主な特許出願者の時間的発展
  • 主な特許出願者のマッピング
  • 出願者の特許ポートフォリオのサマリー
  • 特許出願者のIPリーダーシップ
  • 専門家のレベル
  • 引用判例集の分析
  • 特許ポートフォリオのインデックス
  • 特許出願者のIPブロッキングの可能性
  • 特許出願者のIPネットワーク
  • 主な特許ファミリー
  • 満了が近い認可特許

技術的な課題

  • 主なIPクラス
  • 時間的発展:IPC
  • 主なプライオリティ諸国/主なIPCのマトリックス
  • 主な出願者のマトリクス/主なIPC
  • 検索方式
  • マテリアル
  • 疾患
  • 診断技術
  • 結論

主な特許訴訟

主要企業のIPプロファイル

  • Abbott
  • Agilent Technologies
  • Becton Dickinson
  • Caltech
  • GPB Scientific
  • HP
  • MGH
  • Micronics
  • MIT
  • Philips
  • Roche
  • Samsung Electronics
  • Siemens
  • Ningbo University
  • University of California
    • 企業紹介
    • 特許ポートフォリオのサマリー
    • 主な特許

結論

KnowMadeについて

目次

Microfluidic technologies have brought numerous advantages in diagnostic applications: smaller systems, small sample volume, near-patient technologies, reduced processing time and cost reduction. The scope of applications for microfluidic technologies for diagnostic applications is very broad: genetic, infectious, oncology, blood coagulation or cardiac pathology. It impacts therapeutic approaches by allowing a specific and quick detection and characterization of the disease as well as an easier evolution monitoring.

The patent landscape related to microfluidic technologies claiming diagnostic applications is very open, providing space for both academic and industrial applicants. This landscape represents more than 1,150 families, including over 4,500 patents, and over 500 patent applicants are involved. Surprisingly, several important market players on the field of microfluidic technologies do not appear among the main patent applicants, and unexpected companies in this field, such as HP, have filed a lot of patents recently. Thereby this report provides an interesting overview on the IP situation.

Microfluidics are cross-disciplinary technologies and a lot of patented systems can be adapted for various applications. Therefore, although some key market companies do not appear among the main patent assignees, they are nevertheless involved in several patent infringement cases. Moreover, our partner Yole Développement has estimated recently that the market for microfluidic chips and microfluidic-based tests for point-of-need testing applications, which is only a part of microfluidic for diagnostic domain, should increase from $6 billion in 2015 to $ 17.2 billion in 2021. Thus, the number of patent litigations cases related to microfluidic technologies in the biomedical domain is expected to increase. Therefore, it is essential to know key patent applicants in this area and understand their IP strategies.

The analysis of the technical issues addressed by patents related to microfluidic technologies for diagnostic applications supports what we observed on the market. This indicates that the patented technologies are linked to the market and have a high potential for application.

IDENTIFY KEY PLAYERS

The report provides a ranking and analysis of the relative strength of the top patent holders derived from their portfolio size, patent citation networks, countries of patent filings, current legal status of patents. Through this thorough analysis, we have identified 10+ major players, each of which is profiled in this report. Each profile includes a detailed portfolio analysis with patent activities, key patents, impact of portfolio, granted patents near expiration and IP strategies. The IP landscape for microfluidic technologies for diagnostic applications is shared between industrial and academic players. Among the main applicants, a lot of American companies appear.

IDENTIFY MAIN CURRENT IP APPLICANTS

The IP activity of American applicants involved in microfluidic technologies for diagnostic applications can explain the predominance of US patent filings observed. However, all non-American main applicants also choose US as main priority country. China and Europe represent a particular interest for further patent extensions. Current main IP applicants include players with a steady IP activity who are extending their portfolio to different countries as well as new players with an intense IP activity in 2016.

STRENGTH INDEX OF PATENT PORTFOLIOS

The strength index of a patent portfolio is linked to the number of forward citations received. In this analysis, Caltech is ranked first with a medium sized patent portfolio. Caltech owns two key patent families claiming microfluidic nucleic acid analysis and its patent portfolio is cited a lot by Fluidigm. Other, such as Ningbo University, hold large portfolio, but it shows a very low strength index. Its patented technologies are rather young and have currently a very low impact in the domain of microfluidics for diagnostic applications.

USEFUL PATENT DATABASE (4,500+ patents)

This report also includes an Excel database containing all of the analyzed patents. The database allows for multi-criteria searches and includes patent publication number, hyperlinks to the original documents, priority date, title, abstract, patent assignees and legal status for each member of the patent family.

COMPANIES AND ACADEMICS CITED IN THE REPORT (NON-EXHAUSTIVE)

Abbot, Agilent, Alere, BD, Bio-Techne, Caliper, Caltech, Cellectricon, Fluidigm, Fluxion Biosciences, GPB Scientific, Gyros, HandyLab, HP, Idex, Illumina, MGH, Micronics, MIT, Ningbo University, PerkinElmer, Philips, ProteinSimple, Roche Diagnostics, Samsung Electronics, Siemens, University of California

Table of Contents

INTRODUCTION

  • Microfluidic technologies for diagnostic applications
  • Scope of the report
  • Related reports
  • Key features of the report
  • Objectives of the reports

METHODOLOGY

  • Patent search, selection and analysis
  • Search strategy
  • Terminologies for patent analysis

MAIN ASSIGNEES

EXECUTIVE SUMMARY

PATENT LANDSCAPE OVERVIEW

  • Time evolution of patent publications
  • Countries of patent filings
  • Time evolution by country of filing
  • Ranking of main patent applicants
  • Ranking of main players
  • Time evolution of main patent applicants
  • Countries of filings for main patent applicants
  • Mapping of main current IP holders
  • Mapping of main current IP applicants
  • Summary of applicant's patent portfolio
  • IP leadership of patent applicants
  • Degree of specialization
  • Citations analysis
  • Strength index of patent portfolios
  • IP blocking potential of patent applicants
  • Patent applicants IP network
  • Key patent families
  • Granted patents near expiration

TECHNICAL ISSUES

  • Main IPC classes
  • Time evolution by IPC
  • Matrix main priority countries / main IPC
  • Matrix main applicants / main IPC
  • Search equations
  • Material
  • Disease
  • Diagnostic technique
  • Conclusions

MAIN PATENT LITIGATIONS

IP PROFILE OF KEY PLAYERS

  • Abbott
  • Agilent Technologies
  • Becton Dickinson
  • Caltech
  • GPB Scientific
  • HP
  • MGH
  • Micronics
  • MIT
  • Philips
  • Roche
  • Samsung Electronics
  • Siemens
  • Ningbo University
  • University of California
  • For each player:
  • Company presentation
  • Summary of the patent portfolio
  • Key patents

CONCLUSION

KNOWMADE PRESENTATION

Back to Top